Pricing Log in Create free account

Nuwellis, Inc. (NUWE) vs Vivos Therapeutics, Inc. (VVOS)

Nuwellis, Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Vivos Therapeutics, Inc. is the larger, with a market value of $3.5M against $2.5M — 1.4× the size. Vivos Therapeutics, Inc. grew revenue faster over the last twelve months: 45.2% against 8.36%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −125.6%) and the lower return on invested capital (−592.7% vs 0.00%). Across the 17 metrics below, Vivos Therapeutics, Inc. leads on 11 and Nuwellis, Inc. on 6.

Valuation

Metric NUWE VVOS Medical Devices median
P/E n/m n/m 24.94
P/S 0.01 0.08 2.66
P/B n/m n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.01 0.38 2.76
Earnings yield (17,689.52%) (2,111.11%) (12.66%)
Free cash flow yield (13,863.65%) (1,194.75%) (7.18%)

Profitability

Metric NUWE VVOS Medical Devices median
Gross margin 69.69% 61.89% 57.76%
Operating margin (142.87%) (107.89%) (14.84%)
Net margin (125.57%) (121.79%) (14.45%)
Free cash flow margin (140.67%) (90.97%) (5.70%)
Return on equity 205.50% 10,022.05% (10.56%)
Return on assets (123.52%) (101.46%) (17.26%)
Return on invested capital 0.00% (592.70%) (5.22%)

Growth

Metric NUWE VVOS Medical Devices median
Revenue growth (TTM) 8.36% 45.21% 10.41%
EPS growth (last fiscal year) 92.81% 6.76% 28.17%
Revenue growth, 5-year CAGR 2.14% 5.95% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NUWE VVOS Medical Devices median
Debt to equity 0.00 (2.04) 0.04
Current ratio 1.97 0.21 2.67
Net debt to EBITDA 0.10 (0.37) 0.54

Dividend

Metric NUWE VVOS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric NUWE VVOS Medical Devices median
Market cap 2.52m 3.45m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack